Transforming Drug Discovery through AI and Single-Cell Multiomics with Cellarity

We've got a new episode of Data in Biotech! This week we're joined by Parul Bordia Doshi from Cellarity.

This was a fascinating conversation with Ross Katz that took us from exploring some of the biggest challenges facing Chief Data Officers, particularly for organizations with data-centric propositions, to looking at some of the practical approaches that ensure data scientists can extract the maximum amount of value from all available data.

We also covered:

• The benefits that come through hiring multilingual, multidisciplinary teams and putting a strong focus on collaboration.

• How Cellarity is using GenAI and single-cell multiomics to design therapies that target the entire cellular system.

• The future of data science for drug discovery, plus a look at Cellarity’s ongoing collaboration with Novo Nordisk on the development of novel therapeutics.

Listen wherever you get your podcasts.

Apple: https://lnkd.in/guesQvAV
Spotify: https://lnkd.in/gKg2fmUj